Trial · NCT03784794
Patient Blood Management for Massive Obstetric Hemorrhage
NCT03784794, Not applicable, Completed, Angel Augusto Perez Calatayud
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Patient Blood Management for Massive Obstetric Hemorrhage. Trials, record NCT03784794. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03784794
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Patient Blood Management for Massive Obstetric Hemorrhage
- NCT number
- NCT03784794
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 100 participants, actual
- Lead sponsor
- Angel Augusto Perez Calatayud
- Conditions
- Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired, Massive Hemorrhage, Transfusion Related Complication
- Interventions
- Thromboelastometry, Standard Coagulation Test, Fibrinogen Concentrate Human, Prothrombin Complex Concentrates, Platelets, Red Blood Cells, Fresh Frozen Plasma, cryoprecipitates
- First posted
- 2018-12-24
- Last updated
- 2021-06-08
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Blood products transfused | 24 hrs | Number of allogeneic blood products transfused intra-op, within 24h after screening and in-hospital (RBC, Platelets and FFP; separate and overall) |
| Secondary | Number of hemocomponents or fibrinogen concentrates needed to treat hypofibrinogenemia | day 0 to day 15 | Number of packs of Cryo (pack of 5 \~ 1 G Fibrinogen), Fibrinogen Concentrate (G), and PCC (500 UI) administered intra-operating |
| Secondary | Incidence of Red Blood Cells transfusion (RBC) | day 0 to day 15 | Incidence ≥ 5 U RBC transfused |
| Secondary | Incidence of Massive Red Blood Cells transfusion (RBC) | day 0 to day 15 | Incidence ≥ 10 U RBC transfused (first 24h after screening) |
| Secondary | estimated blood loss | day 0 to day 15 | Overall estimated blood loss (EBL, ML) |
| Secondary | Time to bleeding control | 24 hrs | time from study entry to last hemostatic intervention/transfusion |
| Secondary | Incidence of coagulopathy | day 0 to day 15 | detected by thromboelastometry or standard coagulation laboratory tests |
| Secondary | Incidence of hysterectomy | day 0 to day 15 | number of obstetric hysterectomy for bleeding control |
| Secondary | Incidence of re-surgery | day 0 to day 15 | number of procedures necessary for bleeding control |
| Secondary | Incidence of Transfused associated circulatory overload | day 0 to day 15 | number of patients with transfused associated circulatory overload |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers12
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03784794
GET https://conductscience.org/api/trials/v1/NCT03784794/registered